Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modeling of Aniridia-Related Keratopathy by CRISPR/Cas9 Genome Editing of Human Limbal Epithelial Cells and Rescue by Recombinant PAX6 Protein

29 May 2018

Abstract excerpt

Heterozygous PAX6 gene mutations leading to haploinsufficiency are the main cause of congenital aniridia, a rare and progressive panocular disease characterized by reduced visual acuity. Up to 90% of patients suffer from aniridia-related keratopathy (ARK), caused by a combination of factors including limbal epithelial stem cell (LSC) deficiency, impaired healing response and abnormal differentiation of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Corneal surgery and disorders
Share to Corneal Surgery and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29808941
DOI: 10.1002/stem.2858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modeling of Aniridia-Related Keratopathy by CRISPR/Cas9 Genome Editing of Human Limbal Epithelial Cells and Rescue by Recombinant PAX6 ProteinPMID 29808941Read ↗

Cell signaling pathways in human mutant PAX6 corneal cells: an in vitro model for aniridia-related keratopathySemantic proximity Read ↗

A human-like model of aniridia-associated keratopathy for mechanistic and therapeutic studies.Semantic proximity Read ↗

Pathophysiology of aniridia-associated keratopathy: Developmental aspects and unanswered questionsSemantic proximity Read ↗

Production and Limbal Lineage Commitment of Aniridia Patient-Derived Induced Pluripotent Stem CellsSemantic proximity Read ↗

PAX6 disease models for aniridiaSemantic proximity Read ↗

Therapeutic applications of CRISPR /Cas9 gene editing technology for the treatment of ocular diseasesSemantic proximity Read ↗

Gene expression study in the siRNA based aniridia cell model and in primary aniridia limbal epithelial cells following duloxetine and ritanserin treatmentSemantic proximity Read ↗

A review of the clinical and genetic aspects of aniridia.Semantic proximity Read ↗

New horizons in aniridia management: Clinical insights and therapeutic advancesSemantic proximity Read ↗

Future directions in managing aniridia-associated keratopathySemantic proximity Read ↗

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseasesSemantic proximity Read ↗

Congenital aniridia variant: minimally abnormal irides with severe limbal stem cell deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.